Get started
Author

Susan A. VanMeter

Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors
2005 · Michael E. Thase, Barbara R. Haight, et al. · The Journal of Clinical Psychiatry · 303
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis
2018 · Amit Bar-Or, Richard A. Grove, et al. · Neurology · 219
PDF
Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest
2006 · James W. Jefferson, A. John Rush, et al. · The Journal of Clinical Psychiatry · 59
Challenges and opportunities in designing clinical trials for neuromyelitis optica
2015 · Brian G. Weinshenker, Gerard Barron, et al. · Neurology · 45
PDF
The MIRROR Study: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Investigate the Safety and MRI Efficacy of Subcutaneous Ofatumumab in Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS) (S23.006)
2014 · Amit Bar-Or, Richard Grove, et al. · Neurology · 27
Pyrimidine Nucleos(t)ide Therapy in Patients With Thymidine Kinase 2 Deficiency
2025 · Cristina Domínguez-González, Carl Chiang, et al. · Neurology · 18
Dose Response of Gabapentin Enacarbil versus Placebo in Subjects with Moderate-to-Severe Primary Restless Legs Syndrome
2012 · Susan A. VanMeter, Sarah T. Kavanagh, et al. · CNS Drugs · 18
A randomized, fixed-dose, dose–response Study of Ropinirole Prolonged Release in Advanced Parkinson’s Disease
2017 · Theresa A Zesiewicz, Stephen Chriscoe, et al. · Neurodegenerative Disease Management · 16
PDF
Prevalence of Hepatic Encephalopathy from a Commercial Medical Claims Database in the United States
2021 · Aniruddha Potnis, Susan VanMeter, et al. · International Journal of Hepatology · 15
PDF
A fixed-dose, dose–response Study of Ropinirole Prolonged Release in Early Stage Parkinson’s Disease
2017 · Theresa A Zesiewicz, Stephen Chriscoe, et al. · Neurodegenerative Disease Management · 13
PDF
Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease
2014 · Clare W. Makumi, Afsaneh Asgharian, et al. · International Journal of Neuroscience · 13
Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect Studies in Healthy Adults
2024 · Aravind Mittur, Susan A. VanMeter, et al. · Clinical Therapeutics · 7
PDF
Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency
2026 · Michio Hirano, Caterina Garone, et al. · Brain Communications · 4
The Disease Course of Untreated Patients with Thymidine Kinase 2 Deficiency (TK2d) Aged >12 Years at TK2d Symptom Onset: Findings from the Largest International TK2d Dataset (P2-11.020)
2025 · Cristina Domínguez-González, Andrés Nascimento Osorio, et al. · Neurology · 3
The MIRROR Study: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Investigate the Safety and MRI Efficacy of Subcutaneous Ofatumumab in Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS) (I7-1.007)
2014 · Amit Bar-Or, Richard Grove, et al. · Neurology · 3
Disease burden of untreated thymidine kinase 2 deficiency: insights from a large patient dataset
2026 · Cristina Domínguez-González, Caterina Garone, et al. · Brain Communications · 2
The Disease Course of Untreated Patients with Thymidine Kinase 2 Deficiency (TK2d) Aged ≤12 Years at TK2d Symptom Onset: Findings from the Largest International TK2d Dataset (P10-6.007)
2025 · Michio Hirano, Andrés Nascimento Osorio, et al. · Neurology · 2
Post hoc analysis using PRO-ACT database to evaluate Repository Corticotropin Injection (H.P. Acthar® Gel) as a potential treatment for ALS (P5.327)
2018 · Susan VanMeter, Patrice Becker, et al. · Neurology · 2
Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single‐Dose Phase 1 Study
2026 · Aravind Mittur, Susan A. VanMeter · Clinical Pharmacology in Drug Development · 1
PDF
71PSafety of pyrimidine nucleos(t)ide therapy in Thymidine kinase 2 deficiency: an integrated analysis from a pooled dataset
2025 · C. Domínguez-González, C. Garone, et al. · Neuromuscular Disorders · 1
Su1057 The Burden of Comedication Among Inflammatory Bowel Disease Patients
2013 · Jessie P. Buckley, Michael Kappelman, et al. · Gastroenterology · 1
521P Methodology and design of a study to characterize the disease course in a large dataset of patients with thymidine kinase 2 deficiency
2024 · C. Domínguez-gonzález, A. Nascimento, et al. · Neuromuscular Disorders
Rationale and Design for a Multicenter, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects with Amyotrophic Lateral Sclerosis (P5.331)
2018 · Susan VanMeter, Patrice Becker, et al. · Neurology
Works count: 24
Citation count: 772
H-index: 11
I10-index: 11
Year
Topic
Type